4//SEC Filing
Kelly Patrick F. 4
Accession 0000899243-22-007921
CIK 0001538927other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 5:08 PM ET
Size
5.8 KB
Accession
0000899243-22-007921
Insider Transaction Report
Form 4
Kelly Patrick F.
SVP, Chief Medical Officer
Transactions
- Sale
Common Stock
2022-02-23$9.78/sh−5,245$51,283→ 64,884 total
Footnotes (3)
- [F1]Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units, and does not represent a discretionary trade by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.61 to $10.005. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F3]The Form 4 filed by the reporting person on March 2, 2021 inadvertently understated the number of shares of Common Stock directly held by the reporting person by 42,959 shares.
Documents
Issuer
Forma Therapeutics Holdings, Inc.
CIK 0001538927
Entity typeother
Related Parties
1- filerCIK 0001814771
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 5:08 PM ET
- Size
- 5.8 KB